TP53 and Alzheimer disease: In the cortex and hippocampus of AlCl3-administered mice, fisetin reduced Aβ aggregation and the levels of p53, cytochrome c and caspase-9 and -3 and restored the Bax/Bcl-2 ratio, suggesting that it could be effective in slowing down or preventing AD [273].